Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter β΅ to start review
Explore by Goal
"The aim of science is not to open the door to infinite wisdom, but to set a limit to infinite error."
- Bertolt Brecht
Quick Answer
Copied
Core claim
The paper reports that CD9 is required for timely cutaneous wound re-epithelialization in mice, and that CD9 loss leads to persistent JNK hyperactivation, elevated MMP-9, excessive degradation of type IV collagen, basement-membrane defects, and delayed epidermal migrationβpartly rescuable by JNK inhibition.
Long Answer
Paper Review (Visual + Critical): CD9 Is Critical for Cutaneous Wound Healing through JNK Signaling
Journal of Investigative Dermatology (published ~Sept 2011; DOI: 10.1038/jid.2011.268)
Below are only the numeric values stated in the provided text (e.g., fold-changes and relative lengths). Everything else remains qualitative in this visualization because exact values werenβt provided.
Reported value: βOn day 7 post wounding, 75% of wounds were closed in wild-type controls, but none in CD9-null mice.β
Reported values: day 3/5/7 migrating epidermis length in CD9-null is 105% / 71% / 62% of WT.
Reported values: phospho-JNK levels in CD9-null are 2.7Γ / 3.4Γ / 2.4Γ higher than WT at days 3, 5, 7.
Mechanistic chain (as stated)
The authors propose a pathway: CD9 deficiency β sustained epidermal JNK phosphorylation β increased MMP-9 (expression/activity) β increased type IV collagen degradation β defective basement membrane β impaired epidermal migration β delayed re-epithelialization.
Reported: phospho-JNK vs MMP-9 shows r β 0.86, P < 0.01 (in CD9-null wounds).
In vivo genetics + multiple readouts: CD9-null mice were compared with littermate WT, and the phenotype is tracked across macroscopic closure, histology (wound/dermal gape), and mechanistic markers (phospho-JNK, MMP-9 activity/expression, type IV collagen deposition/degradation fragments).
Pathway perturbation consistent with causality: JNK inhibition (SP600125) reduced phospho-JNK, normalized MMP-9 expression/activity to WT-like levels, reduced collagen degradation, and accelerated wound closure/migration in CD9-null mice.
Potential limitations / blind spots (what could weaken the inference)
Cell-type attribution is mostly correlative by staining: Phospho-JNK and MMP-9 staining are described as βprimarily in migrating epidermis,β but the text excerpt doesnβt show single-cell quantification or cell-autonomous genetic control (e.g., epidermis-specific Cd9 deletion). This leaves open contributions from other wound-resident cells (e.g., macrophages/endothelium) beyond epidermal migration.
Incomplete rescue implies additional pathways: Even when JNK suppression normalized MMP-9 and reduced collagen degradation, the wound healing kinetics in inhibitor-treated CD9-null mice were not identical to WT controls (e.g., only ~30% closed at day 7 vs 75% in WT, as described in the provided discussion).
Specificity of pharmacologic inhibitors: The mechanism assumes SP600125 is acting through JNK to influence MMP-9 and collagen degradation. Without orthogonal genetic JNK perturbation in this specific model (not provided in the excerpt), off-target effects or partial pathway compensation remain a general interpretive concern.
What would most strongly disprove the paperβs main causal chain?
Demonstrate that in CD9-null wounds, phospho-JNK and/or MMP-9 are not elevated (or not causally downstream), yet the healing defect persistsβi.e., phenotypes decoupled from the measured JNK/MMP-9 axis.
Show that restoring type IV collagen deposition at the basement membrane rescues migration and closure without affecting MMP-9/JNK activityβcontradicting the idea that MMP-9βmediated collagen degradation is the key upstream driver.
Visual mechanism diagram (text-only, faithfully derived from reported statements)
CD9 loss
β persistent phospho-JNK in migrating epidermis
β β MMP-9 (mRNA + protein + enzymatic activity)
β β type IV collagen degradation (β40-kDa fragment; β160-kDa deposition at basement membrane)
β defective basement membrane
β β epidermal migration
β delayed re-epithelialization / wound closure.
Each arrow corresponds to the paperβs reported observations and inhibitor results in the provided full-text/abstract.
How to go deeper in BGPT
Author reviews (BGPT links)
Feedback:
Updated: May 01, 2026
BGPT Paper Review
Study Novelty
70%
The paper connects CD9 (a tetraspanin previously implicated in diverse processes) to a specific in vivo wound-healing mechanism via a CD9βJNKβMMP-9βtype IV collagen/basement membrane axis, which is a targeted mechanistic advance for cutaneous wound biology rather than a brand-new pathway discovery.
Scientific Quality
70%
Overall strong qualitative-to-phenotype consistency with in vivo genetic perturbation plus pathway-rescue by JNK inhibition and MMP-9 inhibition (supporting causality). Skeptical caveats: the provided excerpt emphasizes staining localization and pharmacologic inhibition; the excerpt also indicates JNK suppression does not fully restore WT healing, implying additional contributing pathways/cell types not fully resolved in the reported text.
Study Generality
60%
The results are clearly about cutaneous wound re-epithelialization in a mouse model and a specific pathway involving JNK/MMP-9/type IV collagen. Translational or mechanistic generality to other wound types or human physiology is not established in the provided text.
Study Usefulness
70%
Mechanistically useful for generating testable hypotheses linking CD9-controlled signaling to ECM basement-membrane remodeling in epidermal migration; useful as a conceptual framework for further experiments in wound healing and ECM regulation.
Study Reproducibility
60%
Methods are described at a moderate level (mouse model, excisional wound size, inhibitor dosing route/timing, and major assay types). However, the provided excerpt does not specify all procedural details needed for full independent replication (e.g., exact antibody sources/dilutions, exact sample sizes per figure panel beyond partial statements, and complete supplementary methods).
Explanatory Depth
70%
The paper provides a coherent causal chain with multiple intermediate molecular endpoints (phospho-JNK, MMP-9 expression/activity, type IV collagen degradation fragments, basement membrane changes) and functional endpoints (closure/gape, migrating epidermis length). Remaining explanatory gaps include cell-autonomous dissection of epidermal CD9 versus contributions from other CD9-expressing wound compartments.
It extracts reported timepoint fold-changes (phospho-JNK, migrating epidermis ratios, closure %) into a dataframe and reproduces Plotly summary charts for mechanistic comparison across days.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
A simple model where CD9-null delays healing solely by reducing keratinocyte proliferation is unlikely because the excerpt reports no obvious proliferation difference (PCNA staining/Western).
A model where elevated MMP-9 is independent of JNK is unlikely given the reported co-variation of phospho-JNK and MMP-9 and the normalization of MMP-9 after JNK suppression.
Science Art
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)
Discussion
Stay current without chasing every paper.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.